Vildagliptin-Induced Acute Pancreatitis-Reference-Cited by-同舟云学术

Vildagliptin-Induced Acute Pancreatitis

Published:2011-05 Issue:3 Volume:17 Page:e48-e50
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Girgis Christian M.,Champion Bernard L.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://aace.metapress.com/index/K278N76127758116.pdf

Reference10 articles.

1. Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes;Richter;Vasc Health and Risk Manag,2008

2. US Food and Drug Administration. MedWatch 2009 Safety Alerts for Human Medical Products: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis. September 25, 2009. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm

3. An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of phase II and III clinical trials;Ligueros-Saylan;Diabetes Obes Metab,2010

4. Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas;Nachnani;Diabetologia,2010

5. Exenatide (exendin-4)-induced pancreatitis: A case report;Denker;Diabetes Care,2006

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of DBPR108 (prusogliptin) as an add‐on to metformin therapy in patients with type 2 diabetes: A 24‐week, multi‐centre, randomized, double‐blind, placebo‐controlled, superiority, phase III clinical trial;Diabetes, Obesity and Metabolism;2022-07-22

2. Ever-increasing diversity of drug-induced pancreatitis;World Journal of Gastroenterology;2020-06-14

3. The paradox of dipeptidyl peptidase IV inhibition in enterocytic differentiation and epithelial-mesenchymal transition in rat cholestatic sepsis;Toxicology and Applied Pharmacology;2020-05

4. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations;PLOS ONE;2020-04-17

5. Sixty Years of Drug Discovery for Type 2 Diabetes: Where Are We Now?;Methods in Molecular Biology;2019-10-05